androstenedione has been researched along with diethylnitrosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanck, A; Eriksson, LC; Hällström, IP | 1 |
| Assefaw-Redda, Y; Blanck, A; Ekvärn, S; Eriksson, LC; Gustafsson, JA; Hällström, IP | 1 |
2 other study(ies) available for androstenedione and diethylnitrosamine
| Article | Year |
|---|---|
Loss of sexual differentiation of metabolism of steroids and xenobiotics in nodular hepatic tissue from male and female Wistar rats treated according to the resistant hepatocyte model.
Topics: 2-Acetylaminofluorene; Androstenedione; Animals; Cytochrome P-450 Enzyme System; Diethylnitrosamine; Female; Hepatectomy; Hydroxylation; Liver; Liver Neoplasms, Experimental; Male; Microsomes, Liver; Oxazines; Rats; Rats, Inbred Strains; Sex Characteristics; Sulfotransferases | 1990 |
Growth hormone administration after treatment in the resistant hepatocyte model does not affect progression of rat liver carcinogenesis.
Topics: 2-Acetylaminofluorene; Androstenedione; Animals; Body Weight; Cell Division; Diethylnitrosamine; Female; Growth Hormone; Injections, Subcutaneous; Kidney Neoplasms; Liver Neoplasms, Experimental; Male; Microsomes, Liver; Rats; Rats, Wistar; Sex Characteristics | 1994 |